Soccer Legend Boosts Cannabis Company In London Stock Exchange Debut

0.9 min readPublished On: February 4th, 2021By

LONDON, England – A cannabinoids company backed by David Beckham and benefiting from his super-stardom will this week become the first company of its kind to formally unveil plans for a main London stock market debut.

Reports from Sky News in England, reveal that Cellular Goods, which makes skincare and athletic recovery products manufactured from biosynthetic cannabinoids, will announce its intention to float as soon as Thursday morning

The company, which is run by Alexis Abraham, has sold a minority stake to DB Ventures, the former Manchester United and England midfielder’s global brand management and commercial ventures arm, according to people close to the situation.

Beckham is understood to believe that the use of CBD in consumer goods as an attractive growth prospect for his investment portfolio, they added.

His decision to take a stake in Cellular Goods is likely to prompt speculation about a future licensing agreement between them.

Cannabis companies have launched a frenetic race to go public in London following changes announced last year to Financial Conduct Authority rules allowing them to list if they have a medical application.

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!